Icon (ICLR) Competitors $174.00 -5.43 (-3.03%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$173.92 -0.08 (-0.05%) As of 09/19/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICLR vs. MEDP, CRL, IQV, TMO, TCOM, RDDT, WCN, GRAB, AER, and RBAShould you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Thermo Fisher Scientific (TMO), Trip.com Group (TCOM), Reddit (RDDT), Waste Connections (WCN), Grab (GRAB), Aercap (AER), and RB Global (RBA). Icon vs. Its Competitors Medpace Charles River Laboratories International IQVIA Thermo Fisher Scientific Trip.com Group Reddit Waste Connections Grab Aercap RB Global Icon (NASDAQ:ICLR) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation. Do institutionals & insiders hold more shares of ICLR or MEDP? 95.6% of Icon shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Comparatively, 20.3% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, ICLR or MEDP? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.70$791.47M$9.7217.90Medpace$2.11B6.64$404.39M$13.4537.07 Do analysts recommend ICLR or MEDP? Icon currently has a consensus price target of $216.67, suggesting a potential upside of 24.52%. Medpace has a consensus price target of $422.27, suggesting a potential downside of 15.31%. Given Icon's stronger consensus rating and higher possible upside, analysts clearly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.68Medpace 3 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.94 Does the media favor ICLR or MEDP? In the previous week, Medpace had 14 more articles in the media than Icon. MarketBeat recorded 20 mentions for Medpace and 6 mentions for Icon. Medpace's average media sentiment score of 1.31 beat Icon's score of 1.14 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 16 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ICLR or MEDP more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.82% 10.95% 6.23% Medpace 18.74%67.66%21.86% Which has more volatility & risk, ICLR or MEDP? Icon has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Icon News Delivered to You Automatically Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICLR vs. The Competition Export to ExcelMetricIconMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.05B$7.89B$5.77B$10.45BDividend YieldN/A2.77%5.61%4.58%P/E Ratio17.90163.9780.5026.81Price / Sales1.7072.29458.4992.96Price / Cash8.6825.1737.6661.43Price / Book1.4847.8015.756.39Net Income$791.47M$241.92M$3.30B$271.80M7 Day Performance-0.57%87.88%5.35%3.51%1 Month Performance-0.97%48.98%7.28%9.58%1 Year Performance-42.59%39.26%80.79%28.53% Icon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICLRIcon4.1855 of 5 stars$174.00-3.0%$216.67+24.5%-42.6%$14.05B$8.28B17.9041,900Positive NewsMEDPMedpace4.3145 of 5 stars$496.41+1.2%$422.27-14.9%+36.3%$13.78B$2.11B36.915,900Positive NewsCRLCharles River Laboratories International4.6231 of 5 stars$152.47-0.3%$177.07+16.1%-24.5%$7.52B$4.05B-114.6420,100Positive NewsAnalyst RevisionIQVIQVIA4.9486 of 5 stars$186.20-0.5%$229.64+23.3%-22.7%$31.83B$15.41B26.9588,000Positive NewsTMOThermo Fisher Scientific4.9677 of 5 stars$474.73-1.0%$592.24+24.8%-21.8%$181.05B$42.88B27.46125,000Positive NewsTCOMTrip.com Group3.868 of 5 stars$74.12+0.3%$76.98+3.9%+61.4%$48.26B$7.30B20.3141,073Positive NewsRDDTReddit3.4514 of 5 stars$264.13+3.9%$184.13-30.3%+302.7%$47.59B$1.30B240.112,233Trending NewsAnalyst ForecastInsider TradeWCNWaste Connections4.9214 of 5 stars$175.71-0.2%$215.00+22.4%-2.7%$45.27B$8.92B70.8523,854Analyst ForecastGRABGrab1.94 of 5 stars$6.14+2.3%$5.82-5.3%+75.5%$24.16B$2.80B153.5411,267Trending NewsAnalyst ForecastHigh Trading VolumeAERAercap2.2994 of 5 stars$120.13-1.7%$122.57+2.0%+23.8%$22.84B$8.00B7.47740Short Interest ↑RBARB Global4.1929 of 5 stars$116.75-0.3%$124.33+6.5%+40.9%$21.74B$4.28B57.807,800News CoveragePositive News Related Companies and Tools Related Companies MEDP Alternatives CRL Alternatives IQV Alternatives TMO Alternatives TCOM Alternatives RDDT Alternatives WCN Alternatives GRAB Alternatives AER Alternatives RBA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICLR) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
